84 related articles for article (PubMed ID: 6085522)
1. Interpretation of lymphocytotoxicity assays and the demonstration of auto-tumor reactive lymphocytes in patients: central issues of present day tumor immunology.
Klein E
Tokai J Exp Clin Med; 1983 Dec; 8(5-6):385-98. PubMed ID: 6085522
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of cell-mediated cytotoxicity at the single cell level. VI. Direct assessment of the cytotoxic potential of human peripheral blood non-lytic effector-target cell conjugates.
Bonavida B; Lebow LT; Bradley TP
J Immunol; 1984 Feb; 132(2):594-8. PubMed ID: 6606675
[TBL] [Abstract][Full Text] [Related]
3. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG
Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
[TBL] [Abstract][Full Text] [Related]
4. Lysis of fresh human tumor cells by autologous large granular lymphocytes and T-lymphocytes: two distinct killing activities induced by coculture with autologous tumor.
Uchida A; Moore M
J Natl Cancer Inst; 1984 Dec; 73(6):1285-92. PubMed ID: 6239944
[TBL] [Abstract][Full Text] [Related]
5. Experimental and clinical data for the role of NK-cells in immunosurveillance.
Klein E; Vánky F; Masucci MG; Bejarano MT
Behring Inst Mitt; 1984 May; (74):140-8. PubMed ID: 6206839
[TBL] [Abstract][Full Text] [Related]
6. Natural killer and tumor recognizing lymphocyte activity in tumor patients.
Klein E; Vánky F; Vose BM
Haematologia (Budap); 1978-1979; 12(1-4):107-12. PubMed ID: 395038
[TBL] [Abstract][Full Text] [Related]
7. In vitro generation of human activated lymphocyte killer cells: separate precursors and modes of generation of NK-like cells and "anomalous" killer cells.
Burns GF; Triglia T; Werkmeister JA
J Immunol; 1984 Sep; 133(3):1656-63. PubMed ID: 6611374
[TBL] [Abstract][Full Text] [Related]
8. Central issues in present-day tumor immunology: interpretation of lymphocytotoxicity assays and the demonstration of auto-tumor-reactive lymphocytes in patients.
Klein E
Transplant Proc; 1981 Mar; 13(1 Pt 2):723-8. PubMed ID: 6168071
[No Abstract] [Full Text] [Related]
9. Interferon effect on cytotoxicity of peripheral blood and tumor-associated lymphocytes against human ovarian carcinoma cells.
Allavena P; Introna M; Sessa C; Mangioni C; Mantovani A
J Natl Cancer Inst; 1982 Apr; 68(4):555-62. PubMed ID: 6175786
[TBL] [Abstract][Full Text] [Related]
10. Natural killer cell activity and autologous tumor killing activity in cancer patients: overlapping involvement of effector cells as determined in two-target conjugate cytotoxicity assay.
Uchida A; Yanagawa E
J Natl Cancer Inst; 1984 Nov; 73(5):1093-100. PubMed ID: 6593485
[TBL] [Abstract][Full Text] [Related]
11. Antagonistic effects of interferons on the cytotoxicity mediated by natural killer cells.
Trinchieri G; Santoli D; Granato D; Perussia B
Fed Proc; 1981 Oct; 40(12):2705-10. PubMed ID: 6169557
[TBL] [Abstract][Full Text] [Related]
12. Lymphokine-activated killer cells: lysis of fresh syngeneic natural killer-resistant murine tumor cells by lymphocytes cultured in interleukin 2.
Rosenstein M; Yron I; Kaufmann Y; Rosenberg SA
Cancer Res; 1984 May; 44(5):1946-53. PubMed ID: 6608989
[TBL] [Abstract][Full Text] [Related]
13. Studies on the mechanism of natural killer cell-mediated cytotoxicity. V. Lack of NK specificity at the level of induction of natural killer cytotoxic factors in cultures of human, murine, or rat effector cells stimulated with mycoplasma-free cell lines.
Wright SC; Bonavida B
J Immunol; 1984 Dec; 133(6):3415-23. PubMed ID: 6491292
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the lysis of fresh human solid tumors by autologous lymphocytes activated in vitro with phytohemagglutinin.
Mazumder A; Grimm EA; Rosenberg SA
J Immunol; 1983 Feb; 130(2):958-64. PubMed ID: 6848602
[TBL] [Abstract][Full Text] [Related]
15. Identification of human natural killer soluble cytotoxic factors (NKCF) derived from NK-enriched lymphocyte populations: specificity of generation and killing.
Farram E; Targan SR
J Immunol; 1983 Mar; 130(3):1252-6. PubMed ID: 6822733
[TBL] [Abstract][Full Text] [Related]
16. Selective inhibition of human and mouse natural killer tumor recognition using retroviral antisense in primary natural killer cells: involvement with MHC class I killer cell inhibitory receptors.
Ortaldo JR; Mason AT; Mason LH; Winkler-Pickett RT; Gosselin P; Anderson SK
J Immunol; 1997 Feb; 158(3):1262-7. PubMed ID: 9013968
[TBL] [Abstract][Full Text] [Related]
17. Characterization of cloned cytotoxic lymphocytes with NK-like activity.
Acha-Orbea H; Groscurth P; Lang R; Stitz L; Hengartner H
J Immunol; 1983 Jun; 130(6):2952-9. PubMed ID: 6189907
[TBL] [Abstract][Full Text] [Related]
18. Lymphocyte-mediated cytotoxicity against allogeneic tumour cells. IV. Fine specificity mapping and characterization of concanavalin A-activated cytotoxic effector lymphocytes.
Waterfield JD; Nixon DF; Mair MG
Immunology; 1981 Dec; 44(4):685-93. PubMed ID: 6797935
[TBL] [Abstract][Full Text] [Related]
19. Limiting dilution analysis of the frequency of human T cells and large granular lymphocytes proliferating in response to interleukin 2. I. The effect of lectin on the proliferative frequency and cytotoxic activity of cultured lymphoid cells.
Vose BM; Bonnard GD
J Immunol; 1983 Feb; 130(2):687-93. PubMed ID: 6600251
[TBL] [Abstract][Full Text] [Related]
20. Studies on the mechanism of natural killer cell-mediated cytotoxicity. IV. Interferon-induced inhibition of NK target cell susceptibility to lysis is due to a defect in their ability to stimulate release of natural killer cytotoxic factors (NKCF).
Wright SC; Bonavida B
J Immunol; 1983 Jun; 130(6):2965-8. PubMed ID: 6189909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
